(Q34924287)

5 August 2017

0 references

1 reference

title

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis (English)

1 reference

5 August 2017

0 references

1 reference

R G Ghalie

1

1 reference

5 August 2017

E Mauch

2

1 reference

5 August 2017

G Edan

3

1 reference

5 August 2017

H P Hartung

4

1 reference

5 August 2017

R E Gonsette

5

1 reference

5 August 2017

S Eisenmann

6

1 reference

5 August 2017

E Le Page

7

1 reference

5 August 2017

M D Butine

8

1 reference

5 August 2017

D E De Goodkin

9

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Multiple Sclerosis Journal

5 August 2017

published in

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

441-445

1 reference

Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

Mitoxantrone immunotherapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involve

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS836OA

10.1191/1352458502MS836OA

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference